SECsense Logo

IDEXX Laboratories Inc. 8-K Filing: Key Updates for Investors (Feb 2025)

$IDXX
Form 8-K
Filed on: 2025-02-14
Source
IDEXX Laboratories Inc. 8-K Filing: Key Updates for Investors (Feb 2025)

Based on the provided section of the financial report, here are the key pieces of information and insights extracted:

  1. Entity Information:
  • Company Name: IDEXX Laboratories Inc.
  • CIK Number: 0000874716
  • SEC Central Index Key: 000-19271
  • EIN: 01-0393723
  • Address: One IDEXX Drive, Westbrook, ME 04092
  • Contact Number: 207-556-0300
  1. Filing Information:
  • Filing Type: 8-K (a report used to notify investors of major events that are important to shareholders)
  • Filing Date: February 13, 2025
  1. Stock Information:
  • Stock Type: Common Stock
  • Par Value: $0.10 per share
  • Stock Symbol: IDXX
  • Exchange: NASDAQ
  1. Filing Context:
  • The report relates to a specific event or disclosure that occurred on the same day as the filing, February 13, 2025.
  1. General Observations:
  • The filing is categorized under "DE" which indicates that it is a definitive agreement or related to certain transactions.
  • The document indicates that it is not applicable for certain sections, possibly relating to financials or specific disclosures that do not apply to this 8-K.

Overall, this 8-K filing provides essential updates regarding IDEXX Laboratories Inc., particularly for investors and analysts looking for timely information on company developments or events that could affect stock performance.